JP2005508952A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508952A5
JP2005508952A5 JP2003534419A JP2003534419A JP2005508952A5 JP 2005508952 A5 JP2005508952 A5 JP 2005508952A5 JP 2003534419 A JP2003534419 A JP 2003534419A JP 2003534419 A JP2003534419 A JP 2003534419A JP 2005508952 A5 JP2005508952 A5 JP 2005508952A5
Authority
JP
Japan
Prior art keywords
ylmethyl
tetrahydroquinolin
piperazine
cyclohexanecarbonyl
indolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003534419A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508952A (ja
Filing date
Publication date
Priority claimed from IT2001MI002060A external-priority patent/ITMI20012060A1/it
Application filed filed Critical
Publication of JP2005508952A publication Critical patent/JP2005508952A/ja
Publication of JP2005508952A5 publication Critical patent/JP2005508952A5/ja
Withdrawn legal-status Critical Current

Links

JP2003534419A 2001-10-05 2002-10-07 尿路障害の処置における使用のためのヘテロ環式化合物 Withdrawn JP2005508952A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002060A ITMI20012060A1 (it) 2001-10-05 2001-10-05 Nuovi eterocilcli n-acilati
PCT/EP2002/011282 WO2003031436A1 (en) 2001-10-05 2002-10-07 Heterocyclic compounds for use in the treatment of disorders of the urinary tract

Publications (2)

Publication Number Publication Date
JP2005508952A JP2005508952A (ja) 2005-04-07
JP2005508952A5 true JP2005508952A5 (enExample) 2006-01-05

Family

ID=11448476

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003534419A Withdrawn JP2005508952A (ja) 2001-10-05 2002-10-07 尿路障害の処置における使用のためのヘテロ環式化合物

Country Status (32)

Country Link
US (2) US20030181446A1 (enExample)
EP (1) EP1432701B1 (enExample)
JP (1) JP2005508952A (enExample)
KR (1) KR20040048930A (enExample)
CN (1) CN1564820A (enExample)
AP (1) AP1705A (enExample)
AR (1) AR036743A1 (enExample)
AT (1) ATE313540T1 (enExample)
AU (1) AU2002346979B9 (enExample)
BR (1) BR0213067A (enExample)
CA (1) CA2458456A1 (enExample)
CO (1) CO5570679A2 (enExample)
CY (1) CY1104991T1 (enExample)
DE (1) DE60208221T2 (enExample)
DK (1) DK1432701T3 (enExample)
EA (1) EA200400507A1 (enExample)
EC (1) ECSP045095A (enExample)
ES (1) ES2253568T3 (enExample)
HR (1) HRP20040392A2 (enExample)
HU (1) HUP0401598A2 (enExample)
IT (1) ITMI20012060A1 (enExample)
MA (1) MA27067A1 (enExample)
MX (1) MXPA04002962A (enExample)
NO (1) NO20041833L (enExample)
NZ (1) NZ532511A (enExample)
OA (1) OA12663A (enExample)
PL (1) PL369763A1 (enExample)
SI (1) SI1432701T1 (enExample)
TN (1) TNSN04053A1 (enExample)
WO (1) WO2003031436A1 (enExample)
YU (1) YU27204A (enExample)
ZA (1) ZA200403356B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035521A1 (es) * 2000-12-22 2004-06-02 Lundbeck & Co As H Derivados de 3-indolina y composicion farmaceutica que los comprende
WO2003007956A1 (en) * 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
US20040058962A1 (en) * 2002-06-14 2004-03-25 Amedeo Leonardi Phenylalkylamines and pyridylalkylamines
US20040215284A1 (en) * 2003-01-30 2004-10-28 Recordati S.A. Treatment of neuromuscular dysfunction of the lower urinary tract with selective mGlu5 antagonists
UY28538A1 (es) * 2003-09-26 2005-04-29 Vertex Pharma Derivados de fenil-piperazina como moduladores de receptores muscarínicos
KR20060123452A (ko) * 2003-12-09 2006-12-01 버텍스 파마슈티칼스 인코포레이티드 나프티리딘 유도체 및 무스카린 수용체의 조절자로서의이의 용도
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
US7553967B2 (en) * 2004-03-12 2009-06-30 Wyeth 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
DE102005027168A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Tetrahydrochinoline
WO2007134149A2 (en) 2006-05-11 2007-11-22 Janssen Pharmaceutica N.V. 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors
EP2034998A1 (en) 2006-05-11 2009-03-18 Janssen Pharmaceutica, N.V. 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors
FR2902790A1 (fr) * 2006-06-27 2007-12-28 Sanofi Aventis Sa Derives d'urees de piperidine ou pyrrolidine,leur preparation et leur application en therapeutique
PE20080344A1 (es) 2006-06-27 2008-06-09 Sanofi Aventis Compuestos 8-azabiciclo[3.2.1]oct-8-il-1,2,3,4-tetrahidroquinolina sustituidos como inhibidores 11b-hsd1
PE20080212A1 (es) * 2006-06-27 2008-04-25 Sanofi Aventis Derivados de ureas de piperidina o pirrolidina como moduladores de la 11b-hidroxiesteroide deshidrogenasa tipo 1 (11bhsd1)
AU2007275736A1 (en) 2006-07-19 2008-01-24 Osurf (Ohio State University Research Foundation) Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
WO2009025477A1 (en) * 2007-08-17 2009-02-26 Lg Life Sciences Ltd. Indole compounds as an inhibitor of cellular necrosis
WO2009132307A1 (en) 2008-04-24 2009-10-29 The Regents Of The University Of California Small-molecule inhibitors of the androgen receptor
FR2969151B1 (fr) * 2010-12-17 2016-11-04 Oreal Derives du 4-amino et leur utilisation pour la coloration d'oxydation des fibres keratiniques.
WO2015035278A1 (en) * 2013-09-09 2015-03-12 Bristol-Myers Squibb Company RORγ MODULATORS
US9725443B2 (en) 2013-09-20 2017-08-08 Bristol-Myers Squibb Company RORγ modulators
AR107032A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
CN108299397B (zh) * 2018-03-21 2019-01-29 佳木斯大学附属第一医院 一种用于降血压的活性药物及其制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1027611A (en) * 1962-01-04 1966-04-27 May & Baker Ltd Phenoxy- and phenylthio-alkylamines and acid addition salts thereof
GB1166538A (en) * 1967-06-10 1969-10-08 Pfizer Ltd Substituted Tetrahydroquinolines
US3983121A (en) * 1974-07-01 1976-09-28 Council Of Scientific And Industrial Research 1-Substituted 4-(β-2-quinolylethyl)piperazines and 1,2,3,4-tetrahydroquinolyl-ethyl analogues thereof
US4011324A (en) * 1976-01-20 1977-03-08 Pfizer Inc. Esters and amides of pyrimido[4,5-b]quinolin-4(3H)-one-2-carboxylic acids as antiulcer agents
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
CH653021A5 (fr) * 1981-04-24 1985-12-13 Delalande Sa Derives piperidino, piperazino et homopiperazino, n-substitues par un groupe heterocyclique aromatique, leur procede de preparation et composition therapeutique les contenant.
US4585773A (en) * 1984-07-11 1986-04-29 Bristol-Myers Company Isoindolinyl-alkyl-piperazines
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5641504A (en) * 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
MX9200038A (es) * 1991-01-09 1992-11-01 Alza Corp Dispositivos biodegradables y composiciones para la liberacion por difusion de agentes.
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な3環性キノキサリンジオン誘導体
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
ATE185694T1 (de) * 1992-05-13 1999-11-15 Alza Corp Oxybutynin zur transdermalen verabreichung
US5512293A (en) * 1992-07-23 1996-04-30 Alza Corporation Oral sustained release drug delivery device
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5533971A (en) * 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
IT1270993B (it) * 1994-03-18 1997-05-26 Recordati Chem Pharm Derivati chinzolilamminici attivi come alfa-antagonisti
FR2729144A1 (fr) * 1995-01-06 1996-07-12 Smithkline Beecham Lab Nouvelles diamines, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu' agents anti-arythmiques
US5859014A (en) * 1995-06-09 1999-01-12 Syntex (U.S.A.) Inc. Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonists
US5780058A (en) * 1995-07-21 1998-07-14 Alza Corporation Oral delivery of discrete units
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
DE69739986D1 (de) * 1996-10-01 2010-10-21 Kyowa Hakko Kogyo Kk Stickstoff enthaltende heterocyclische verbindungen
CA2220649C (en) * 1996-12-03 2007-02-13 F. Hoffmann-La Roche Ag 4-hydroxy-piperidine derivatives
EP0846683B1 (en) * 1996-12-03 2001-09-19 F. Hoffmann-La Roche Ag 4-Hydroxy-piperidine derivatives
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
US6130200A (en) * 1996-12-20 2000-10-10 Alza Corporation Gel composition and methods
US6169086B1 (en) * 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
WO1999006382A1 (en) * 1997-08-01 1999-02-11 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293804B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6039977A (en) * 1997-12-09 2000-03-21 Alza Corporation Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods
NZ506435A (en) * 1998-03-26 2002-08-28 Shionogi & Co 3-Indoly-2-hydroxy-4-oxo-2-butanoic acid useful as antiviral activity
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
US6306861B1 (en) * 1999-07-30 2001-10-23 Recordati S.A. Chemical And Pharmaceutical Company Thienopyrancecarboxamide derivatives
US6403594B1 (en) * 1999-10-18 2002-06-11 Recordati, S.A. Chemical And Pharmaceutical Company Benzopyran derivatives
US6365591B1 (en) * 1999-10-18 2002-04-02 Recordati, S.A., Chemical And Pharmacueticals Company Isoxazolecarboxamide derivatives
AR035521A1 (es) * 2000-12-22 2004-06-02 Lundbeck & Co As H Derivados de 3-indolina y composicion farmaceutica que los comprende
US20030060513A1 (en) * 2001-09-27 2003-03-27 Arneric Stephen P. Pharmaceutical composition
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati

Similar Documents

Publication Publication Date Title
JP2005508952A5 (enExample)
AU2002346979B2 (en) Heterocyclic compounds for use in the treatment of disorders of the urinary tract
AU2002346979A1 (en) Heterocyclic compounds for use in the treatment of disorders of the urinary tract
TWI386405B (zh) 咪唑衍生物
USRE41425E1 (en) Piperazine and piperidine compounds
NO322220B1 (no) Nye forbindelser, deres anvendelse og fremstilling
JP2004522792A5 (enExample)
EP0930298A1 (en) Fluorinated 1,4-disubstituted piperidine derivatives
JPWO2010107115A1 (ja) グリシントランスポーター阻害物質
EP1881975B1 (en) N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
HUP0301458A2 (hu) Benzoxazinonszármazékok, eljárás előállításukra és a vegyületek felhasználása
EP3728233A1 (en) Substituted pyrrolidine amides ii
CA2927153A1 (en) Methylene linked quinolinyl modulators of ror-gamma-t
KR100517387B1 (ko) 벤젠술폰아미드 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물
KR20200003097A (ko) 2-([1,2,3]트리아졸-2-일)-벤조산 유도체의 제조
CA2011834A1 (en) Indole derivatives
DE60218529T2 (de) Isochroman verbindungen für die behandlung von cns-krankheiten
EP2451803B1 (en) Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein
US7335660B2 (en) Isochroman compounds for treatment of CNS disorders
HK1067362B (en) Heterocyclic compounds for use in the treatment of disorders of the urinary tract
HK1124238A (en) Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxylase tyrosine inducers